Skip to main content
66 search results for:

EULAR 2021 

sort by |
"newest" sorts results by publication date. "most relevant" also considers factors like how often the search phrase is in the result.
  1. 24-05-2021 | EULAR 2021 conference hub | Teaser

    EULAR 2021 Virtual Congress coverage

    Access news and expert commentary from the EULAR 2021 Virtual Congress.

  2. 24-05-2021 | EULAR 2021 | Conference coverage | Channel

    EULAR 2021 Virtual Congress

    Coverage from the EULAR 2021 Virtual Congress.

  3. 30-08-2022 | COVID-19 | News | Article

    Studies bolster evidence for COVID-19 vaccination in young people with RMDs

    Reassuring safety results in adolescents with a range of RMDs The second study, from Kimme Hyrich (Manchester University NHS Foundation Trust, UK) and team, focused on the safety profile of COVID-19 vaccination in 36 adolescents (median age 15 years) with RMDs – including JIA (42%), SLE (14%), and spondyloarthropathies (14%) – who were included in the EULAR COVAX registry in 2021–2022.

  4. 11-08-2022 | Guidelines | News | Article
    guidelinesWatch

    Updated European guidance on vaccination issued for pediatric rheumatology patients

    Click through for more details on the EULAR recommendations

  5. 02-06-2022 | EULAR 2022 | Conference coverage | Article
    News in brief

    Mortality risk may be ‘slightly increased’ in women with polymyalgia rheumatica

    Women with polymyalgia rheumatica may have a small increase in the risk for mortality relative to the general population, but not during the first 20 years after diagnosis, according to research presented at the EULAR 2022 Congress in Copenhagen, Denmark.

  6. 03-06-2022 | EULAR 2022 | Conference coverage | Article

    Chronic, low-dose glucocorticoid benefits outweigh harms in senior patients with RA

    “Taking all these findings together, they seem to suggest that withdrawal of low-dose prednisolone is feasible after 2 years of administration,” Almayali concluded. medwireNews is an independent medical news service provided by Springer Healthcare Ltd. © 2022 Springer Healthcare Ltd, part of the Springer Nature Group EULAR 2022; Copenhagen, Denmark: 1–4 June Ann Rheum Dis 2022; doi:10.1136/annrheumdis-2021-221957 Ann Rheum Dis  2022; 81 : 180

  7. 02-06-2022 | EULAR 2022 | Conference coverage | Article

    ​​​​​​​Research highlights need to minimize corticosteroid use during pregnancy

    As reported at the EULAR 2022 Congress in Copenhagen, Denmark, Sabrina Hamroun (Cochin Hospital, Paris, France) and fellow researchers evaluated pregnancy outcomes in 92 women with RA who were included in the French national GR2 cohort between 2015 and 2021.

  8. 06-04-2022 | Sjögren’s syndrome | News | Article
    News in brief

    Baricitinib warrants further investigation for primary Sjögren’s syndrome

    They found that among 11 patients with pSS and moderate-to-high disease activity, average EULAR pSS Disease Activity Index (ESSDAI) scores improved significantly from 10.0 points at baseline to 3.4 points after 6 months of treatment with baricitinib 2 mg/day.

  9. 21-02-2022 | Cardiovascular disease | News | Article
    News in brief

    EULAR releases recommendations on CV risk management in RMD patients

    EULAR has issued recommendations for managing cardiovascular risk in people with antiphospholipid syndrome, gout, mixed connective tissue disease, myositis, Sjögren’s syndrome, systemic lupus erythematosus, systemic sclerosis, or vasculitis.

  10. 10-02-2022 | ANCA-associated vasculitis | News | Article

    ACR, EULAR issue classification criteria for ANCA-associated vasculitis

    “These criteria have been endorsed by the ACR [American College of Rheumatology] and EULAR and are now ready for use to differentiate one type of vasculitis from another to define populations in research studies,” write Peter Merkel (University of Pennsylvania, Philadelphia, USA) and colleagues.

  11. 28-02-2022 | COVID-19 | News | Article
    News in brief

    SLE disease activity, glucocorticoid use linked to more severe COVID-19 outcomes

    A total of 1606 individuals with SLE and COVID-19 who were included in the GRA or EULAR COVID-19 registries between March 2020 and June 2021 were categorized into four groups of COVID-19 severity.

  12. 17-12-2021 | Systemic sclerosis | News | Article

    VEDOSS criteria may help predict progression from Raynaud’s to SSc

    Del Galdo and team report that 254 participants completed the 5-year study of whom 52.4% progressed to meet the 2013 ACR–EULAR classification criteria for SSc.

  13. 01-03-2021 | COVID-19 | Feature | Article

    COVID-19 vaccination in patients with rheumatic diseases

    “This data will be an important contribution to the arguments brought forward to encourage patients to be vaccinated,” said EULAR in an announcement about the survey. medwireNews is an independent medical news service provided by Springer Healthcare Ltd. © 2021 Springer Healthcare Ltd, part of the Springer Nature Group 1 March 2021: The coronavirus pandemic is affecting all healthcare professionals across the globe.

  14. 07-11-2021 | ACR 2021 | Conference coverage | Article

    High rates of severe COVID-19 in patients with vasculitis, polymyalgia rheumatica

    An analysis of data from the COVID-19 Global Rheumatology Alliance and EULAR COVID-19 registries suggests high rates of severe COVID-19 among people with primary systemic vasculitis or polymyalgia rheumatica.

  15. 08-11-2021 | ACR 2021 | Conference coverage | Article

    Positive phase 2b results for ianalumab in primary Sjögren’s syndrome

    ACR Convergence 2021; 3–9 November

  16. play
    02-06-2021 | EULAR 2021 | Conference coverage | Video

    COVID-19 Global Rheumatology Alliance study finds link between RA treatment and COVID-19 severity

    EULAR 2021 video: Jeffrey Sparks and Zachary Wallace talk about their findings from a COVID-19 Global Rheumatology Alliance study that shows

  17. 22-10-2021 | Dermatomyositis | News | Article

    New EULAR/ACR dermatomyositis criteria shed light on disease frequency, mortality

    A population-based cohort study using the 2017 EULAR/American College of Rheumatology criteria for dermatomyositis has identified a higher incidence, prevalence, and associated mortality rate than previously reported.

  18. 06-11-2021 | ACR 2021 | Conference coverage | Article

    KEEPsAKE trials show benefits of risankizumab in patients with PsA

    Treatment with the IL-23 inhibitor risankizumab may improve outcomes for patients with psoriatic arthritis, suggests an integrated analysis of data from the KEEPsAKE 1 and 2 studies presented at the ACR Convergence 2021 virtual meeting.

  19. 12-10-2021 | COVID-19 | News | Article
    News in brief

    EULAR updates guidance on immunomodulatory treatment for COVID-19

    EULAR has updated its points to consider on the use of immunomodulatory therapies for the treatment of COVID-19 in light of the most recent evidence.

  20. 23-09-2021 | Myositis | News | Article

    Myositis-specific autoantibodies could aid inflammatory myopathy classification

    The team concludes: “Although challenging, we propose that confirming these results in additional myositis cohorts and revising the IM classification criteria to utilize MSAs should be priorities of the international myositis community.” medwireNews is an independent medical news service provided by Springer Healthcare Ltd. © 2021 Springer Healthcare Ltd, part of the Springer Nature Group Arthritis Rheumatol 2021 doi:10.1002/art.41964

Filter search results

Search Operators:

„ ... ... “ Finds documents with exactly this word group, in exactly this word order and spelling (e.g., "employer branding").
AND Finds documents with both search terms (e.g., sales AND bonus).
OR Finds documents with one or the other search term (e.g., porsche OR volkswagen).
Blank Space Finds documents with all search terms. Blank space is understood as AND (e.g., man robot production).
NOT Finds documents with no appearance of the word behind NOT (e.g., ford NOT "harrison ford").
COUNT(...)>n Finds documents where the search term is mentioned at least "n" times."n" may be any number (e.g., COUNT(gear)>8).
NEAR(..., ..., ) Finds documents with both search terms in any word order, permitting "n" words as a maximum distance between them. Best choose between 15 and 30 (e.g., NEAR(recruit, professionals, 20)).
* Finds documents with the search term in word versions or composites. The star * marks whether you wish them BEFORE, BEHIND, or BEFORE and BEHIND the search term (e.g., lightweight*, *lightweight, *lightweight*).
? Finds documents with the search termn in different spellings."?" allows only one character (e.g., organi?ation).
& + - Special characters are understood as AND (e.g., Miller Bros. & Sons).

You can use operators in your search query to narrow down your results even more.

Tap the operator, or hover the mouse pointer over it, to read more about how it works.